20-Year Follow-up of a Phase 3 RCT: High-Dose Chemotherapy with Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial – JAMA Oncology (free for a limited period)

Commentary: Could High-Dose Chemo Return for Select Breast Cancers? – MedPage Today (free registration required)